Product Description
Androsta-5,16-diene-3,17-diol、124643-35-2
AI Product Description
*The following content is generated by AI and is for reference only.
Androsta-5,16-diene-3,17-diol is a specialized synthetic steroid intermediate primarily utilized in the pharmaceutical and biochemical research sectors. Its molecular formula is C19H28O2, reflecting a structure characterized by an androstane backbone featuring double bonds at positions 5 and 16, along with hydroxyl groups at the 3 and 17 positions. While specific CAS registry numbers for this exact diastereomer may vary depending on stereochemical configuration and supplier classification, it is generally recognized as a critical building block for the semi-synthetic production of advanced anabolic steroids and hormone therapies.
The compound serves as a pivotal precursor in complex organic synthesis pathways, particularly for manufacturing potent androgens or their metabolites used in clinical trials. Researchers often employ Androsta-5,16-diene-3,17-diol to investigate metabolic conversion rates, receptor binding affinities, and the structural determinants of biological activity within endocrine systems. Its unique unsaturation pattern at the C16 position distinguishes it from standard testosterone derivatives, offering distinct pharmacokinetic properties that are valuable for developing novel therapeutics targeting muscle wasting conditions, osteoporosis, or hormonal imbalances.
In industrial applications, this molecule is frequently handled under strict laboratory conditions due to its potency and potential regulatory status as a controlled substance precursor in various jurisdictions. It is not intended for direct human consumption but rather functions as a high-purity reagent for academic institutions and biotechnology firms. The synthesis of this compound typically requires sophisticated catalytic methods to ensure precise regioselectivity and stereoselectivity, ensuring the final product meets rigorous analytical standards required for drug development. As the demand for personalized medicine grows, intermediates like this play an increasingly vital role in accelerating the pipeline from basic chemical discovery to viable medical treatments. Consequently, accurate sourcing and handling protocols are essential for safety and compliance.